Spain: Pancreatic Cancer Mortality, by year
YearNumber of deaths
20227,973
20217,663
20207,427
20197,313
20187,120
20176,868
20166,789
20156,406
20146,287
20136,039
20125,976
20115,812
20105,716
20095,242
20085,233
20074,976
20064,860
  • Region: Spain
  • Time period: 2006 to 2022
  • Published: Feb 2024

Data Analysis and Insights

Updated: Mar 28, 2024 | Published by: Statistico

Steady Increase in Deaths from 2006 to 2022

Deaths caused by pancreatic cancer in Spain have seen a consistent annual increase, from 4,860 deaths in 2006 to 7,973 deaths in 2022. This upward trend reflects a total growth of 63.9% over 16 years, underscoring a significant rise in fatalities associated with this condition.

Year-on-Year Growth Rates

The annual growth rate of deaths due to pancreatic cancer has varied, with the highest increase recorded between 2020 and 2021 at 3.2% (7427 to 7663 deaths). Notably, the period from 2018 to 2019 also saw a notable rise, with a 2.7% increase (7120 to 7313 deaths), indicating periods of heightened mortality rates.

Impact Over the Last Five Years

Examining the data from the last five years reveals a stark acceleration in the number of deaths, with an increase from 6868 deaths in 2017 to 7973 deaths in 2022. This 16.1% rise over a relatively short period highlights the growing impact of pancreatic cancer in Spain, signaling an urgent need for increased awareness and intervention.

Comparison of Early and Recent Years

The comparison between the first five years (2006-2010) and the last five years (2018-2022) in the dataset shows a dramatic change in the mortality rate due to pancreatic cancer. The average annual deaths increased from approximately 5,122 in the early years to 7,599 in the more recent period, marking a 48.4% rise and illustrating the escalating severity of the condition over time.

Lowest to Highest Annual Deaths

The lowest number of annual deaths was observed in 2006, with 4,860 fatalities, while the highest was in 2022, with 7,973 fatalities. The continuous upward trajectory over these years highlights the critical nature of the disease's progression in Spain, marking an increase in both prevalence and potentially the lethality of pancreatic cancer.

Frequently Asked Questions

What is the total growth in pancreatic cancer deaths in Spain from 2006 to 2022?

There was a 63.9% total increase in deaths from pancreatic cancer in Spain from 2006 to 2022.

What was the year with the highest annual growth rate in deaths due to pancreatic cancer?

The highest annual growth rate was between 2020 and 2021 with a 3.2% increase.

Terms and Definitions

Pancreatic cancer refers to a medical condition characterized by the development of malignant cells in the tissues of the pancreas. The pancreas is an organ located near the stomach that secreted enzymes for digestion and produces hormones to regulate sugar in the bloodstream.

Mortality, in the context of medicine, refers to the rate at which people die from a particular cause or condition. In other words, it represents the number of deaths that occur in a specific population or demographic, usually expressed per 1000 or 100,000 population.

Cancer mortality rate is a measure of the number of deaths that occur due to cancer per a given period of time, typically per year. This rate can be specific to a certain type of cancer, age group, or geographical area.

Incidence rate is a measure of the frequency with which a disease or illness occurs in a population over a specific time period. Incidence rate is usually quantified as the number of cases per particular number of people, such as per 1000 or 100,000, over one year.

Survival rate is a metric used in medicine to indicate the percentage of people who survive a certain type of cancer or illness for a specific amount of time after their diagnosis. This is typically expressed in terms of a 5-year survival rate.

Early detection refers to the process of diagnosing a disease or condition in its initial stages, before symptoms are severe or complications arise. For cancer, early detection often improves the potential efficacy of treatment and can significantly increase the chances of survival.

A risk factor is any attribute, factor, or exposure that increases the likelihood of developing a disease or health disorder. In the context of pancreatic cancer, risk factors may include age, smoking, obesity, and having a family history of the disease.

Prevalence refers to the total number of individuals in a given population who have a specific disease or condition at a particular time. It can be presented as a percentage of the total population.

Late stage diagnosis refers to the detection of a disease or condition in its advanced phases, where treatment options may be more limited and less effective. In terms of cancer, a late stage diagnosis often means the cancer has metastasized, or spread, to other parts of the body beyond the primary site.
All statistics
All topics
Cancer
Cancer is a prevalent disease worldwide, affecting millions of people with different types including breast, lung, prostate, and colorectal cancer, among others. Read more »
All locations
Spain
Explore the comprehensive profile of Spain, covering geographic, demographic, and economic data. Discover Spain's position globally in various aspects, from GDP to literacy rate, and delve into details about its cities, culture. Read more »
Share